Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients
dc.contributor.author | Gunes M. | |
dc.contributor.author | Kemik A.S. | |
dc.contributor.author | Pirincci N. | |
dc.contributor.author | Gecit I. | |
dc.contributor.author | Taken K. | |
dc.contributor.author | Yuksel M.B. | |
dc.contributor.author | Kaba M. | |
dc.contributor.author | Eryilmaz R. | |
dc.date.accessioned | 2024-07-22T08:19:11Z | |
dc.date.available | 2024-07-22T08:19:11Z | |
dc.date.issued | 2013 | |
dc.description.abstract | Our aim was to test the hypothesis that preoperative serum levels of matrix metalloproteinase-7 (MMP-7) and -9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) levels correlate with pathological features. Serum levels of MMP-7, and MMP-9 and TIMP-1 were determined in 90 bladder cancer patients and 40 healthy controls using an enzyme linked immunosorbent assay. Preoperative serum MMP-7 and MMP-9 levels were significantly higher in cancer patients than control groups (p<0.001). In contast, serum TIMP-1 levels were lower (p<0.001). Alteration in MMP-7, and MMP-9, and TIMP-1 production may contribute to tumor angiogenesis and be associated with clinic-pathological features. | |
dc.identifier.DOI-ID | 10.7314/APJCP.2013.14.2.873 | |
dc.identifier.issn | 15137368 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17568 | |
dc.language.iso | English | |
dc.publisher | Asian Pacific Organization for Cancer Prevention | |
dc.rights | All Open Access; Gold Open Access; Green Open Access | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Disease Progression | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Matrix Metalloproteinase 7 | |
dc.subject | Matrix Metalloproteinase 9 | |
dc.subject | Middle Aged | |
dc.subject | Tissue Inhibitor of Metalloproteinase-1 | |
dc.subject | Tumor Markers, Biological | |
dc.subject | Urinary Bladder | |
dc.subject | Urinary Bladder Neoplasms | |
dc.subject | gelatinase B | |
dc.subject | matrilysin | |
dc.subject | MMP7 protein, human | |
dc.subject | MMP9 protein, human | |
dc.subject | TIMP1 protein, human | |
dc.subject | tissue inhibitor of metalloproteinase 1 | |
dc.subject | tumor marker | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | article | |
dc.subject | bladder | |
dc.subject | bladder tumor | |
dc.subject | blood | |
dc.subject | disease course | |
dc.subject | female | |
dc.subject | human | |
dc.subject | male | |
dc.subject | metabolism | |
dc.subject | middle aged | |
dc.title | Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients | |
dc.type | Article |